News

Infinity Bio Appoints Brian McKelligon as Chief Executive Officer

Infinity Bio, a biotechnology company pioneering the MIPSA technology, today announced the appointment of Brian McKelligon as Chief Executive Officer. McKelligon, an accomplished leader with extensive experience building and scaling innovative life sciences platforms, will guide the company's next phase of growth, global expansion, and commercial acceleration of its proprietary MIPSA technology.

Casey Frushour In Press Releases

Infinity Bio, Inc. Partners With the Austrian Institute of Technology to Provide Access to Antibody Reactome Profiling in Europe

Infinity Bio service offerings leverage proprietary MIPSA technology to provide unprecedented insights into antibody reactivity for translational research and therapeutic development.

Casey Frushour In Press Releases

Infinity Bio Launches EnviroSIGHT™, the World’s First Comprehensive Environmental Antibody Analysis Service

Breakthrough technology enables high-resolution profiling of immune responses to allergens, microbes, and toxins—unlocking new frontiers in systems immunology and chronic disease research

Casey Frushour In News

Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling

Investment supports platform innovation, commercial scaling, and new service development; Infinity acquires the assets of Serimmune, Inc.

Casey Frushour In Press Releases

Infinity Bio Launches Comprehensive Mouse Antibody Reactome Profiling Service

Now available – completely unbiased, high throughput analysis of antibody binding to the complete mouse proteome with MuSIGHT™

Casey Frushour In News

Management Blueprint Podcast: Simplify Complexity with Ben Larman

Ben Larman, Scientific Founder and Chief Scientific Officer (CSO) of Infinity Bio, is driven by a passion for advancing human health by decoding the complexities of the immune system. We discuss Ben’s Antibody Reactomics Framework and his Complex Data Delivery Framework.

Casey Frushour In Press Releases

Infinity Bio Launches Scientific Advisory Board, Welcomes Dr. Stephen Elledge and Dr. Eran Segal

Advisory Board to guide Infinity Bio's research strategy, driving innovation in disease diagnostics and therapeutic advancements.

Casey Frushour In News

Infinity Bio Wins Gold at the 2024 MarCom Awards for Website Excellence

Infinity Bio is proud to announce that we’ve been awarded a prestigious Gold MarCom Award for our website. This recognition highlights our commitment to not only advancing scientific innovation but also ensuring that our digital presence reflects the cutting-edge work we do in antibody profiling. Our newly designed website was crafted to enhance the user experience, making it easier for our visitors to explore our mission and innovations. We’re honored to be recognized by MarCom for excellence in web design and communication.

Casey Frushour In Press Releases

Infinity Bio Unveils the World’s Most Comprehensive Autoantibody Analysis Service: HuSIGHT-Total™

New service leverages proprietary technology to provide unprecedented insights into antibody autoreactivity for translational research and therapeutic development.

Melanie Hilliard In Press Releases

TEDDY Selects Infinity Bio to Provide Antibody Reactome Services for Large Study

Infinity Bio, Inc. is proud to announce its selection by the TEDDY (The Environmental Determinants of Diabetes in the Young) study to provide comprehensive antibody reactome services for their large cohort. This collaboration marks a significant milestone for Infinity Bio as it continues to advance its mission to deliver cutting-edge immunological insights and solutions.

Resources

Stay current with our recent news, updates, and announcements.

Infinity Bio Appoints Brian McKelligon as Chief Executive Officer

Infinity Bio, Inc. Partners With the Austrian Institute of Technology to Provide Access to Antibody Reactome Profiling in Europe

Infinity Bio Launches EnviroSIGHT™, the World’s First Comprehensive Environmental Antibody Analysis Service

Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling

Infinity Bio Launches Comprehensive Mouse Antibody Reactome Profiling Service

Management Blueprint Podcast: Simplify Complexity with Ben Larman

Infinity Bio Launches Scientific Advisory Board, Welcomes Dr. Stephen Elledge and Dr. Eran Segal

Infinity Bio Wins Gold at the 2024 MarCom Awards for Website Excellence

Infinity Bio Unveils the World’s Most Comprehensive Autoantibody Analysis Service: HuSIGHT-Total™

TEDDY Selects Infinity Bio to Provide Antibody Reactome Services for Large Study